Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Patrick Fromal will oversee SSI’s market expansion, focusing on research, development and delivery of advanced analytical solutions and services to customers.
April 8, 2025
By: Charlie Sternberg
Shimadzu Scientific Instruments (SSI) has appointed Patrick Fromal as its new president, effective April 1, 2025.
Fromal, who previously served as senior vice president of sales and marketing, will oversee SSI’s continued market expansion, focusing on research, development and delivery of advanced analytical solutions and exceptional service to customers in science, industry and academia.
Fromal has more than 30 years of experience with SSI, having started his career with the company in 1994 as a contract intern, then transitioning to a permanent position as a molecular spectroscopy product specialist. He has held roles of increasing leadership responsibility with SSI across technical support, product coordination, sales and marketing, ultimately helping to shape the company’s strategic vision and business growth. His extensive expertise and deep commitment to SSI’s mission have been instrumental in driving success across key markets.
“I am honored to take on this role and continue SSI’s legacy of excellence,” said Fromal. “As we look to the future, I am excited to lead our talented team in delivering cutting-edge analytical solutions, strengthening our partnerships with customers, and expanding product development collaborations with key stakeholders in North America via our new R&D center, ensuring that Shimadzu remains at the forefront of innovation and scientific advancement.”
He succeeds Yoshiaki Maeda, who will assume a new role as managing executive officer in charge of corporate strategy planning and corporate communications, and standard strategy with Shimadzu Corporation in Japan.
Fromal holds a Bachelor of Science degree in chemistry from Virginia Tech.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !